Transforming Laboratory Test Results to Improve Clinical Outcome Predictions in HIV Patients
- 1 April 1998
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 17 (5) , 442-449
- https://doi.org/10.1097/00042560-199804150-00009
Abstract
Transforming natural units of laboratory markers of HIV disease may improve their ability to predict clinical outcomes. The authors examined this issue within a prospective study of 394 patients enrolled in the Swiss HIV Cohort Study (SHCS) between 1991 and 1993. Baseline predictors included CD4+ and CD8+ cell counts, HIV RNA levels, beta2-microglobulin, and age. Outcomes were death and clinical progression. A range of power transformations was applied to each predictor, and the goodness-of-fit of the corresponding proportional hazards models was assessed. The prognostic value of all laboratory variables could be improved on by power transformations. To predict either outcome variable, the "best" transformation of HIV RNA copies and CD8+ cell counts was the logarithm; for beta2-microglobulin, it was power -2. For CD4+ cell counts, the best transformation depended on the outcome variable: it was power 0.2 when predicting survival, and power 0.4 when predicting clinical progression. The single best predictor variable was the ratio of HIV RNA copies per CD4+ cell, for both death (logarithmic transformation) and clinical progression (power -0.1 transformation). Natural units of laboratory variables are not optimal for the prediction of clinical events in HIV-infected patients. Which transformation is best depends on the predictor under consideration.Keywords
This publication has 27 references indexed in Scilit:
- Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 InfectionAnnals of Internal Medicine, 1997
- The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic MillimeterNew England Journal of Medicine, 1996
- Surrogate End Points in Clinical Trials: Are We Being Misled?Annals of Internal Medicine, 1996
- Importance of surrogate markers in evaluation of antiviral therapy for HIV infectionPublished by American Medical Association (AMA) ,1996
- Prognostic Value of Viremia in Patients with Long-Standing Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1996
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDSNew England Journal of Medicine, 1996
- Natural history of HIV-1 cell-free viremiaPublished by American Medical Association (AMA) ,1995
- The predictive value of changes in serologic and cell markers of HIV activity for subsequent clinical outcome in patients with asymptomatic HIV disease treated with zidovudineAIDS, 1995
- Surrogate Markers in AIDS: Where Are We? Where Are We Going?Annals of Internal Medicine, 1992